Electrophysiological biomarkers of sleep and cognition in Dup15q syndrome
Electrophysiological biomarkers of sleep and cognition in Dup15q syndrome
批准号:
9810069
负责人:
Shafali Spurling Jeste
金额:
$22.46万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-05 至 2021-07-31
关键词:
AdultAgeAreaAttenuatedBehaviorBehavior TherapyBiological FactorsBiological MarkersBrainChildClinicalClinical TrialsCognitionCognitiveCountryDataDevelopmentDiseaseElectroencephalographyElectrophysiology (science)EpilepsyEtiologyFutureGABA-A ReceptorGenesGenetic DiseasesGoalsImpaired cognitionInfantIntellectual functioning disabilityInvestigationLightLinkMental Retardation and Developmental Disabilities Research CentersNational Institute of Child Health and Human DevelopmentNeurodevelopmental DisorderPharmacologyPhenotypePhysiologicalPropertyProtein BiosynthesisReceptor GeneResearch PrioritySleepSleep disturbancesSlow-Wave SleepSurrogate EndpointSynapsesSyndromeUBE3A geneautism spectrum disorderbehavior measurementcognitive developmentcohortcomparison groupdensityimprovedinfancyinterestneurodevelopmentneurotransmissionpatient advocacy groupprotein degradationrepositorysignal processingskillssleep abnormalitiessleep physiologysleep qualitysleep spindle
中文摘要
项目摘要
15q11.3-21.1(Dup15q综合征)的重复对智力残疾(ID)、自闭症具有高度渗透性
谱系障碍和癫痫(Finucane等人,2016)。该区域的几个基因,特别是UBE3A
和一组GABAA受体基因,对神经发育至关重要,扰乱突触蛋白
合成和降解以及抑制性神经传递。在之前的一项研究中,我们发现了一个
这种综合征的电生理生物标记物定义为β带振荡增加,可能反映
异常的GABA能神经传递(Frohlich等人,2016)。当我们进一步探索这一特性时
,我们发现这些儿童的睡眠生理严重异常,严重
慢波睡眠减弱,睡眠纺锤体密度降低。健康的睡眠生理学是必要的
强健的认知发展,从早期婴儿期到成年期,(den Bakker等人,2018年;Fogel&Smith,
2011年;Hahn等人,2018年;Tham,Schneider,&Broekman,2017),并且有广泛的证据表明
神经发育障碍的生理性睡眠障碍(Gruber&Wise,2016;Kose,Yilmaz,
Ocakoglu和Ozbaran,2017;Tessier等人,2015)。我们假设睡眠生理学异常直接
破坏Dup15q综合征的认知发展,并可能作为可量化和可修改的
药物甚至行为干预的目标。通过与Dup15q联盟的伙伴关系
(患者权益倡导组织)和我们的加州大学洛杉矶分校智力和发育障碍研究中心(IDDRC),
我们建议对Dup15q综合征的睡眠电生理学和认知进行全面的研究。我们会
收集之前记录的全国Dup15q综合征儿童的过夜临床脑电
并将这些脑电与非综合征型儿童和典型发育不良儿童的脑电进行比较。我们会问
睡眠生理,特别是(1)纺锤波密度,(2)慢波睡眠百分比,(3)峰值百分比
慢波睡眠和(4)睡眠阶段1和2的绝对β功率区分Dup15q综合征和
这些比较组以及这些变量是否与认知和适应技能有关。这一领域
神经发育障碍严重缺乏可量化的电生理生物标记物
疾病机制,睡眠脑电可能是一个强大的生物标志物,揭示了病因
认知障碍,同时也是临床试验的替代终点,特别是Dup15q
综合症。此外,我们已经开发的管道,从建立远程临床脑电图库到
执行半自动睡眠脑电信号处理可以为其他生物标志物研究提供信息
非综合征型的ID。
英文摘要
Project Abstract
Duplications of 15q11.3-21.1 (Dup15q syndrome) are highly penetrant for intellectual disability (ID), autism
spectrum disorder (ASD) and epilepsy (Finucane et al., 2016). Several genes in the region, particularly UBE3A
and a cluster of GABAA receptor genes, are critical for neural development, disrupting synaptic protein
synthesis and degradation as well as inhibitory neurotransmission. In a previous study, we identified an
electrophysiological biomarker of this syndrome defined by increased beta band oscillations that likely reflect
aberrant GABAergic neurotransmission (Frohlich et al., 2016). As we further explored properties of this
biomarker, we discovered that the sleep physiology in these children is profoundly abnormal, with grossly
attenuated slow wave sleep and reduced sleep spindle density. Healthy sleep physiology is necessary for
robust cognitive development, from early infancy through adulthood, (den Bakker et al., 2018; Fogel & Smith,
2011; Hahn et al., 2018; Tham, Schneider, & Broekman, 2017), and there is extensive evidence of
physiological sleep impairment in neurodevelopmental disorders (Gruber & Wise, 2016; Kose, Yilmaz,
Ocakoglu, & Ozbaran, 2017; Tessier et al., 2015). We hypothesize that abnormal sleep physiology directly
undermines cognitive development in Dup15q syndrome and may serve as a quantifiable and modifiable
target for pharmacological or even behavioral interventions. Through a partnership with the Dup15q Alliance
(patient advocacy group) and our UCLA Intellectual and Developmental Disabilities Research Center (IDDRC),
we propose a comprehensive study of sleep electrophysiology and cognition in Dup15q syndrome. We will
collect previously recorded overnight clinical EEG’s from children with Dup15q syndrome across the country
and compare these EEG’s to those of children with nonsyndromic ID and typical development. We will ask
whether sleep physiology, specifically (1) spindle density, (2) percent slow wave sleep, (3) percent spikes in
slow wave sleep and (4) absolute beta power in stage 1 and 2 of sleep differentiates Dup15q syndrome from
these comparison groups and whether these variables relate to cognition and adaptive skills. The field of
neurodevelopmental disorders has sorely lacked quantifiable electrophysiological biomarkers that relate to
disease mechanisms, and sleep EEG may represent a robust biomarker that sheds light on the etiology of
cognitive impairment while also serving as a surrogate endpoint in clinical trials, particularly for Dup15q
syndrome. Moreover, the pipeline that we have developed, from building a remote clinical EEG repository to
performing semi-automated sleep EEG signal processing can inform other biomarker studies in syndromic and
nonsyndromic forms of ID.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Toward Scalable Biomarker-Based Prediction of ASD in High-Risk Infants
-
批准号:10452439
-
项目类别:
-
资助金额:$85.51万
-
财政年份:2021
-
负责人:Shafali Spurling Jeste
-
依托单位:
Toward Scalable Biomarker-Based Prediction of ASD in High-Risk Infants
-
批准号:10475316
-
项目类别:
-
资助金额:$74.94万
-
财政年份:2021
-
负责人:Shafali Spurling Jeste
-
依托单位:
Toward scalable biomarker-based prediction of ASD in high-risk infants
-
批准号:10023280
-
项目类别:
-
资助金额:$78.61万
-
财政年份:2019
-
负责人:Shafali Spurling Jeste
-
依托单位:
Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex
-
批准号:10380038
-
项目类别:
-
资助金额:$48.42万
-
财政年份:2017
-
负责人:Shafali Spurling Jeste
-
依托单位:
Mechanisms of change with early intervention in Tuberous Sclerosis Complex
-
批准号:9921443
-
项目类别:
-
资助金额:$51.87万
-
财政年份:2017
-
负责人:Shafali Spurling Jeste
-
依托单位:
Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex
-
批准号:10461690
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2017
-
负责人:Shafali Spurling Jeste
-
依托单位:
3/5-The Autism Biomarkers Consortium for Clinical Trials
-
批准号:10224937
-
项目类别:
-
资助金额:$91.48万
-
财政年份:2015
-
负责人:Shafali Spurling Jeste
-
依托单位:
3/5-The Autism Biomarkers Consortium for Clinical Trials
-
批准号:10439670
-
项目类别:
-
资助金额:$91.5万
-
财政年份:2015
-
负责人:Shafali Spurling Jeste
-
依托单位:
3/5-The Autism Biomarkers Consortium for Clinical Trials
-
批准号:10675097
-
项目类别:
-
资助金额:$91.33万
-
财政年份:2015
-
负责人:Shafali Spurling Jeste
-
依托单位:
3/5-The Autism Biomarkers Consortium for Clinical Trials
-
批准号:10083890
-
项目类别:
-
资助金额:$82.94万
-
财政年份:2015
-
负责人:Shafali Spurling Jeste
-
依托单位:
Neural Predictors of Language Function After Intervention in Children with Autism
-
批准号:8463251
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2011
-
负责人:Shafali Spurling Jeste
-
依托单位:
Neural Predictors of Language Function After Intervention in Children with Autism
-
批准号:8656439
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2011
-
负责人:Shafali Spurling Jeste
-
依托单位:
Neural predictors of language acquisition after intensive behavioral intervention
-
批准号:8166008
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2011
-
负责人:Shafali Spurling Jeste
-
依托单位:
Neural Predictors of Language Function After Intervention in Children with Autism
-
批准号:8304921
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2011
-
负责人:Shafali Spurling Jeste
-
依托单位:
Beyond Baby Siblings: Early Developmental Trajectories and Biomarkers of Risk for ASD
-
批准号:10228037
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2007
-
负责人:Shafali Spurling Jeste
-
依托单位:
Beyond Baby Siblings: Early Developmental Trajectories and Biomarkers of Risk for ASD
-
批准号:9388804
-
项目类别:
-
资助金额:$27.73万
-
财政年份:--
-
负责人:Shafali Spurling Jeste
-
依托单位:
Neurophysiological biomarkers of cognition in Dup15 syndrome: From mouse models to patients (Project)
-
批准号:9056019
-
项目类别:
-
资助金额:$30.9万
-
财政年份:--
-
负责人:Shafali Spurling Jeste
-
依托单位:
3/5-The Autism Biomarkers Consortium for Clinical Trials
-
批准号:8984983
-
项目类别:
-
资助金额:$74.92万
-
财政年份:--
-
负责人:Shafali Spurling Jeste
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: